Atlas Trials

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

Clinical trial NCT02531880 · RECRUITING

Trial details

NCT number
NCT02531880
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2024-11-19
Primary completion
2030-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.